Shield Therapeutics (GB:STX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Shield Therapeutics has launched a RetailBook Offer, allowing existing UK shareholders to purchase new ordinary shares at a premium price of 3.0p per share, raising up to £1 million. This offer is available through partners like AJ Bell and Hargreaves Lansdown and can be accessed using ISAs or SIPPs. The offer closes on December 20, 2024, with no commission charged by RetailBook.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.
